ClinicalThought

Share

Program Content

Activities

  • PARPi Combo Evidence in PCa
    Expanding the Role of PARP Inhibitors in Prostate Cancer—Innovative Combination Strategies
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 02, 2021

    Expires: July 01, 2022

Provided by

ProCE Banner

Supporters

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer, Inc.